关于性别与健康的特刊:倾听病人的声音

IF 8.5 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Elizabeth Zuccala
{"title":"关于性别与健康的特刊:倾听病人的声音","authors":"Elizabeth Zuccala","doi":"10.5694/mja2.70064","DOIUrl":null,"url":null,"abstract":"<p>In their 2024 work <i>Who's afraid of gender?</i>, Judith Butler<span><sup>1</sup></span> charts the rise of an international so-called anti-gender ideology movement, in which the concept of gender operates as “phantasm”. That is, a site where disparate contemporary fears — be they around the future of work, family life, or other aspects of the world — gather and become weaponised for political ends. This weaponisation of gender is having far-reaching impacts across the globe, including on public health policy and the practice of medicine.<span><sup>2</sup></span> In one of the most striking recent examples, the United States under the Trump Administration is undertaking extraordinary attacks on sexual and reproductive health and rights, in part under the guise of “defending women from gender ideology extremism and restoring biological truth”.<span><sup>3, 4</sup></span> Australia too is seeing its share of backlash against gender equity in the sphere of health, including use of anti-gender ideology discourse to mobilise opposition to health care access for transgender (trans) people.<span><sup>5, 6</sup></span></p><p>It is against this backdrop that the <i>Medical Journal of Australia</i> dedicates a special issue to the topic of gender and health. In doing so, we do not seek to prescribe specific definitions of “sex” or “gender” for adoption across health and medicine. These are often contested terms subject to evolving and varied scholarship, including growing recognition that they might defy efforts to map them neatly onto a “biological” and “cultural” binary.<span><sup>1</sup></span> In line with the Sex and Gender Equity in Research (SAGER) guidelines,<span><sup>7</sup></span> which the journal endorses, these terms should be clearly defined by authors and used with precision and consistency throughout their work. The goal of this special issue is to provide a platform for research and analysis that engage with what gender means for Australian health care in a manner informed by evidence, scientific rigour, a quest for equity and justice and, fundamentally, respect for the rights, dignity and perspectives of affected populations. Its curation was premised on an understanding of gender as “the structure of social relations and practices that are organised in relation to reproductive bodies”.<span><sup>8</sup></span></p><p>The articles in this issue cover diverse ground. Harsha Ananthram and colleagues<span><sup>9</sup></span> seek to unpack the term “obstetric violence” in the context of findings from recent inquiries into birth trauma in Australia and the United Kingdom. In Australia, practitioners who refuse to participate in abortion care should refer their patients onwards to a willing provider. Shelly Makeleff and colleagues<span><sup>10</sup></span> argue that not enough attention has been given to how these referrals are carried out and propose strategies to promote person-centred abortion referrals. The potential to improve the care of people with anxiety disorders through sex- and gender-responsive management approaches is explored by Bronwyn Graham,<span><sup>11</sup></span> who notes that sex and gender are relatively ignored in anxiety disorder research, medical curricula, and clinical guidelines. Findings from a cohort study done in New South Wales show that although the gender gap in the treatment and outcomes of ST-elevation myocardial infarction (STEMI) has narrowed in recent years, the high disparity between male and female patients with STEMI is unlikely to close in the next decade.<span><sup>12</sup></span> And a pharmacoepidemiology study from Kailash Thapaliya and colleagues<span><sup>13</sup></span> highlights gaps in evidence and guidance for the prescribing of glucagon-like peptide-1 (GLP-1) receptor agonists for women of reproductive age.</p><p>Three articles in this special issue specifically address trans health. First, Kade Booth and colleagues<span><sup>14</sup></span> discuss the disparities faced by trans and gender diverse people in accessing cervical cancer screening and vaccination against human papillomavirus, and propose several potential solutions. Second, a perspective article by Julia Moore and colleagues<span><sup>15</sup></span> engages with the <i>Independent review of gender identity services for children and young people</i>, or Cass Review, commissioned by England's National Health Service and published in 2024.<span><sup>16</sup></span> The authors critique the findings of the Review on several grounds, including a lack of representation of the views of trans adolescents, and ultimately conclude the review represents a “failure of evidence-based medicine”. “Good medicine” they contend “is guided by the values of the patient, not those of a clinician, politician or commentator. A patient's goal of achieving optimal quality of life as a trans person requires respect”.</p><p>This point is directly addressed by the third article on trans health in this issue, from Jayne McFadyen and colleagues.<span><sup>17</sup></span> In 1987, the <i>MJA</i> published the report of a case series of eight gender diverse children.<span><sup>18</sup></span> To correct what was termed their “cross-gender behaviour”, these children had been administered “therapy” as inpatients for between six and 28 weeks. The report concluded that “the treatment of cross-gender behaviour by means of inpatient therapy seems effective”. It continues to be cited in contemporary debates about young people's access to gender affirming care and about so-called conversion therapy. Decades later, the <i>MJA</i> was approached by Jayne and her co-authors with a request to consider an article in response to this work: Jayne is a trans woman who reasonably believes, on the basis of evidence available to her, that she was one of the children described in the 1987 article. The author team had undertaken an analysis of archived mental health records, published details from the 1987 case series, and Jayne's autoethnographic account of her treatment, and concluded that the inpatient treatment Jayne had received constituted a form of conversion therapy aimed at “extinguishing childhood behaviours deemed to be socially undesirable”. Despite the claim from the 1987 report that this treatment appeared effective, for Jayne the attempt to change or suppress her gender identity “served to delay self-acceptance for two decades and caused long term harm”.</p><p>As journal editors, at the forefront of our minds every time we decide to publish an article are questions about the potential harms that could result from our decision. We must ask ourselves: are we confident the findings reported are legitimate, produced ethically, analysed appropriately, and reported in a balanced and transparent manner? Could our decisions inadvertently contribute to undermining public trust in science or to supporting ineffective or even harmful medical practices? To mitigate these concerns, we take expert advice from peer reviewers and consider it carefully in the context of what has been previously published. We have no reason to believe that those involved in the 1987 <i>MJA</i> article had anything but the best intentions, given the knowledge and dominant gender norms of the day. But what is apparent is that the practices of medicine and scholarly publishing at the time did not place sufficient value on the views, experiences and preferences of the young people whose wellbeing was at stake. Genuine evidence-based medicine requires epistemic pluralism, including understanding the value of patient voices. This is where the work of Jayne and her colleagues becomes particularly important.</p><p>At the <i>MJA</i>, we appreciate the power imbalances at play here. These exist between medical experts with professional standing, a scholarly journal with an established national reputation, and a patient, who at the time the “inpatient treatment” was administered was a child. In this context, we are immensely grateful that Jayne and her co-authors chose to entrust their work to the <i>MJA</i> for consideration. As editors, we are also grateful for the opportunity this experience has afforded us to reflect and act on what it means to demonstrate institutional accountability for past decisions. What constitutes the best care for trans young people should of course be up for debate, as is the case for all areas of medicine. It is the role of medical journals to ensure that this debate is rooted in humane values and is driven by evidence — of which the views of patients are an essential part.</p>","PeriodicalId":18214,"journal":{"name":"Medical Journal of Australia","volume":"223 7","pages":"329-330"},"PeriodicalIF":8.5000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.70064","citationCount":"0","resultStr":"{\"title\":\"Special issue on gender and health: listening to the voices of patients\",\"authors\":\"Elizabeth Zuccala\",\"doi\":\"10.5694/mja2.70064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In their 2024 work <i>Who's afraid of gender?</i>, Judith Butler<span><sup>1</sup></span> charts the rise of an international so-called anti-gender ideology movement, in which the concept of gender operates as “phantasm”. That is, a site where disparate contemporary fears — be they around the future of work, family life, or other aspects of the world — gather and become weaponised for political ends. This weaponisation of gender is having far-reaching impacts across the globe, including on public health policy and the practice of medicine.<span><sup>2</sup></span> In one of the most striking recent examples, the United States under the Trump Administration is undertaking extraordinary attacks on sexual and reproductive health and rights, in part under the guise of “defending women from gender ideology extremism and restoring biological truth”.<span><sup>3, 4</sup></span> Australia too is seeing its share of backlash against gender equity in the sphere of health, including use of anti-gender ideology discourse to mobilise opposition to health care access for transgender (trans) people.<span><sup>5, 6</sup></span></p><p>It is against this backdrop that the <i>Medical Journal of Australia</i> dedicates a special issue to the topic of gender and health. In doing so, we do not seek to prescribe specific definitions of “sex” or “gender” for adoption across health and medicine. These are often contested terms subject to evolving and varied scholarship, including growing recognition that they might defy efforts to map them neatly onto a “biological” and “cultural” binary.<span><sup>1</sup></span> In line with the Sex and Gender Equity in Research (SAGER) guidelines,<span><sup>7</sup></span> which the journal endorses, these terms should be clearly defined by authors and used with precision and consistency throughout their work. The goal of this special issue is to provide a platform for research and analysis that engage with what gender means for Australian health care in a manner informed by evidence, scientific rigour, a quest for equity and justice and, fundamentally, respect for the rights, dignity and perspectives of affected populations. Its curation was premised on an understanding of gender as “the structure of social relations and practices that are organised in relation to reproductive bodies”.<span><sup>8</sup></span></p><p>The articles in this issue cover diverse ground. Harsha Ananthram and colleagues<span><sup>9</sup></span> seek to unpack the term “obstetric violence” in the context of findings from recent inquiries into birth trauma in Australia and the United Kingdom. In Australia, practitioners who refuse to participate in abortion care should refer their patients onwards to a willing provider. Shelly Makeleff and colleagues<span><sup>10</sup></span> argue that not enough attention has been given to how these referrals are carried out and propose strategies to promote person-centred abortion referrals. The potential to improve the care of people with anxiety disorders through sex- and gender-responsive management approaches is explored by Bronwyn Graham,<span><sup>11</sup></span> who notes that sex and gender are relatively ignored in anxiety disorder research, medical curricula, and clinical guidelines. Findings from a cohort study done in New South Wales show that although the gender gap in the treatment and outcomes of ST-elevation myocardial infarction (STEMI) has narrowed in recent years, the high disparity between male and female patients with STEMI is unlikely to close in the next decade.<span><sup>12</sup></span> And a pharmacoepidemiology study from Kailash Thapaliya and colleagues<span><sup>13</sup></span> highlights gaps in evidence and guidance for the prescribing of glucagon-like peptide-1 (GLP-1) receptor agonists for women of reproductive age.</p><p>Three articles in this special issue specifically address trans health. First, Kade Booth and colleagues<span><sup>14</sup></span> discuss the disparities faced by trans and gender diverse people in accessing cervical cancer screening and vaccination against human papillomavirus, and propose several potential solutions. Second, a perspective article by Julia Moore and colleagues<span><sup>15</sup></span> engages with the <i>Independent review of gender identity services for children and young people</i>, or Cass Review, commissioned by England's National Health Service and published in 2024.<span><sup>16</sup></span> The authors critique the findings of the Review on several grounds, including a lack of representation of the views of trans adolescents, and ultimately conclude the review represents a “failure of evidence-based medicine”. “Good medicine” they contend “is guided by the values of the patient, not those of a clinician, politician or commentator. A patient's goal of achieving optimal quality of life as a trans person requires respect”.</p><p>This point is directly addressed by the third article on trans health in this issue, from Jayne McFadyen and colleagues.<span><sup>17</sup></span> In 1987, the <i>MJA</i> published the report of a case series of eight gender diverse children.<span><sup>18</sup></span> To correct what was termed their “cross-gender behaviour”, these children had been administered “therapy” as inpatients for between six and 28 weeks. The report concluded that “the treatment of cross-gender behaviour by means of inpatient therapy seems effective”. It continues to be cited in contemporary debates about young people's access to gender affirming care and about so-called conversion therapy. Decades later, the <i>MJA</i> was approached by Jayne and her co-authors with a request to consider an article in response to this work: Jayne is a trans woman who reasonably believes, on the basis of evidence available to her, that she was one of the children described in the 1987 article. The author team had undertaken an analysis of archived mental health records, published details from the 1987 case series, and Jayne's autoethnographic account of her treatment, and concluded that the inpatient treatment Jayne had received constituted a form of conversion therapy aimed at “extinguishing childhood behaviours deemed to be socially undesirable”. Despite the claim from the 1987 report that this treatment appeared effective, for Jayne the attempt to change or suppress her gender identity “served to delay self-acceptance for two decades and caused long term harm”.</p><p>As journal editors, at the forefront of our minds every time we decide to publish an article are questions about the potential harms that could result from our decision. We must ask ourselves: are we confident the findings reported are legitimate, produced ethically, analysed appropriately, and reported in a balanced and transparent manner? Could our decisions inadvertently contribute to undermining public trust in science or to supporting ineffective or even harmful medical practices? To mitigate these concerns, we take expert advice from peer reviewers and consider it carefully in the context of what has been previously published. We have no reason to believe that those involved in the 1987 <i>MJA</i> article had anything but the best intentions, given the knowledge and dominant gender norms of the day. But what is apparent is that the practices of medicine and scholarly publishing at the time did not place sufficient value on the views, experiences and preferences of the young people whose wellbeing was at stake. Genuine evidence-based medicine requires epistemic pluralism, including understanding the value of patient voices. This is where the work of Jayne and her colleagues becomes particularly important.</p><p>At the <i>MJA</i>, we appreciate the power imbalances at play here. These exist between medical experts with professional standing, a scholarly journal with an established national reputation, and a patient, who at the time the “inpatient treatment” was administered was a child. In this context, we are immensely grateful that Jayne and her co-authors chose to entrust their work to the <i>MJA</i> for consideration. As editors, we are also grateful for the opportunity this experience has afforded us to reflect and act on what it means to demonstrate institutional accountability for past decisions. What constitutes the best care for trans young people should of course be up for debate, as is the case for all areas of medicine. It is the role of medical journals to ensure that this debate is rooted in humane values and is driven by evidence — of which the views of patients are an essential part.</p>\",\"PeriodicalId\":18214,\"journal\":{\"name\":\"Medical Journal of Australia\",\"volume\":\"223 7\",\"pages\":\"329-330\"},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2025-10-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.70064\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Journal of Australia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.5694/mja2.70064\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Australia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.5694/mja2.70064","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

在他们2024年的作品《谁害怕性别?》,朱迪思·巴特勒(Judith butler)描绘了一场所谓的国际反性别意识形态运动的兴起,在这场运动中,性别的概念被视为“幻象”。也就是说,在这个网站上,不同的当代恐惧——无论是围绕未来的工作、家庭生活,还是世界的其他方面——聚集在一起,并成为政治目的的武器。这种性别武器化正在全球范围内产生深远的影响,包括对公共卫生政策和医学实践的影响在最近一个最引人注目的例子中,特朗普政府领导下的美国正在对性健康和生殖健康及权利进行非同寻常的攻击,部分原因是打着“保护妇女免受性别意识形态极端主义和恢复生物学真相”的幌子。3,4澳大利亚在卫生领域也出现了反对性别平等的反弹,包括利用反性别意识形态话语动员反对跨性别者获得医疗保健。5,6正是在这种背景下,《澳大利亚医学杂志》专门出版了一期关于性别与健康的专题。在这样做的过程中,我们并不试图规定“性”或“社会性别”的具体定义,以供整个卫生和医学部门采用。这些经常是有争议的术语,受到不断发展和不同学术的影响,包括越来越多的人认识到,它们可能会违背将它们整齐地划分为“生物学”和“文化”二元的努力根据该杂志认可的研究中的性别和性别平等(SAGER)指南,这些术语应该由作者明确定义,并在其工作中精确和一致地使用。本期特刊的目标是提供一个研究和分析平台,以证据、科学严谨、追求公平和正义以及从根本上尊重受影响人口的权利、尊严和观点为依据,探讨性别对澳大利亚卫生保健的意义。其管理的前提是对性别的理解是“与生殖体有关的社会关系结构和实践”。这一期的文章涉及方方面面。Harsha Ananthram和他的同事试图在最近对澳大利亚和英国的分娩创伤进行调查的背景下,对“产科暴力”一词进行解读。在澳大利亚,拒绝参与堕胎护理的从业者应该将他们的病人转介给愿意提供堕胎服务的人。Shelly Makeleff和她的同事认为,人们对这些转诊是如何进行的关注不够,并提出了促进以人为本的堕胎转诊的策略。布朗温·格雷厄姆(Bronwyn Graham)探讨了通过对性别和性别敏感的管理方法来改善对焦虑症患者护理的潜力,11他指出,在焦虑症研究、医学课程和临床指南中,性别和性别相对被忽视了。新南威尔士州的一项队列研究结果显示,尽管近年来st段抬高型心肌梗死(STEMI)的治疗和预后方面的性别差异有所缩小,但在未来十年,男性和女性STEMI患者之间的巨大差异不太可能缩小Kailash Thapaliya及其同事的一项药物流行病学研究强调了在为育龄妇女开具胰高血糖素样肽-1 (GLP-1)受体激动剂处方的证据和指导方面的差距。本期特刊中有三篇文章专门讨论跨性别健康问题。首先,Kade Booth和他的同事们讨论了跨性别和性别不同的人在获得宫颈癌筛查和人类乳头瘤病毒疫苗接种方面所面临的差异,并提出了几种可能的解决方案。其次,朱莉娅·摩尔(Julia Moore)及其同事撰写的一篇观点文章与《儿童和年轻人性别认同服务的独立审查》(Cass review)进行了合作,该审查受英国国家卫生服务机构委托,于2024年出版。作者从几个方面批评了该审查的结果,包括缺乏对跨性别青少年观点的代表,并最终得出结论,该审查代表了“循证医学的失败”。他们认为,“好药是由病人的价值观来指导的,而不是由临床医生、政治家或评论家的价值观来指导的。”作为一个变性人,患者追求最佳生活质量的目标需要得到尊重。”Jayne McFadyen及其同事在本期关于跨性别健康的第三篇文章中直接阐述了这一点1987年,MJA发表了关于八个性别不同的儿童的一系列案例的报告为了纠正他们所谓的“跨性别行为”,这些儿童作为住院病人接受了6至28周的“治疗”。报告的结论是“通过住院治疗的方式治疗跨性别行为似乎是有效的”。 在当代关于年轻人获得性别确认护理和所谓的转化治疗的辩论中,它继续被引用。几十年后,杰恩和她的合著者找到了MJA,要求他们考虑写一篇文章来回应这项工作:杰恩是一名跨性别女性,根据她掌握的证据,她有理由相信,她就是1987年那篇文章中描述的孩子之一。提交人小组对存档的心理健康记录、1987年病例系列中公布的细节以及Jayne对其治疗的自我民族志叙述进行了分析,得出的结论是,Jayne接受的住院治疗构成了一种转化治疗形式,旨在“消除被认为不受社会欢迎的童年行为”。尽管1987年的报告声称这种治疗似乎有效,但对杰恩来说,试图改变或压抑自己的性别认同“推迟了20年的自我接纳,并造成了长期的伤害”。作为期刊编辑,每当我们决定发表一篇文章时,我们首先想到的是我们的决定可能造成的潜在危害。我们必须问自己:我们是否相信报告的发现是合法的,合乎道德的,经过适当的分析,并以平衡和透明的方式报告?我们的决定是否会在不经意间破坏公众对科学的信任,或者支持无效甚至有害的医疗实践?为了减轻这些担忧,我们听取同行审稿人的专家建议,并在之前发表的内容的背景下仔细考虑。考虑到当时的知识和占主导地位的性别规范,我们没有理由相信那些参与1987年MJA文章的人有最好的意图。但显而易见的是,当时的医学实践和学术出版并没有充分重视年轻人的观点、经历和偏好,他们的健康受到威胁。真正的循证医学需要认识多元化,包括理解患者声音的价值。这就是杰恩和她的同事们的工作变得尤为重要的地方。在MJA,我们理解这里的权力不平衡。这种关系存在于具有专业地位的医学专家、在全国享有声誉的学术期刊和在接受“住院治疗”时为儿童的病人之间。在这种情况下,我们非常感谢Jayne和她的合著者选择将他们的工作委托给MJA考虑。作为编辑,我们也很感激这次经历给我们提供的机会,让我们反思并采取行动,证明对过去决定的机构问责意味着什么。当然,就像所有医学领域的情况一样,对变性年轻人最好的照顾是什么应该引起争论。医学期刊的作用是确保这场辩论根植于人道价值观,并由证据驱动——而患者的观点是证据的重要组成部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Special issue on gender and health: listening to the voices of patients

Special issue on gender and health: listening to the voices of patients

In their 2024 work Who's afraid of gender?, Judith Butler1 charts the rise of an international so-called anti-gender ideology movement, in which the concept of gender operates as “phantasm”. That is, a site where disparate contemporary fears — be they around the future of work, family life, or other aspects of the world — gather and become weaponised for political ends. This weaponisation of gender is having far-reaching impacts across the globe, including on public health policy and the practice of medicine.2 In one of the most striking recent examples, the United States under the Trump Administration is undertaking extraordinary attacks on sexual and reproductive health and rights, in part under the guise of “defending women from gender ideology extremism and restoring biological truth”.3, 4 Australia too is seeing its share of backlash against gender equity in the sphere of health, including use of anti-gender ideology discourse to mobilise opposition to health care access for transgender (trans) people.5, 6

It is against this backdrop that the Medical Journal of Australia dedicates a special issue to the topic of gender and health. In doing so, we do not seek to prescribe specific definitions of “sex” or “gender” for adoption across health and medicine. These are often contested terms subject to evolving and varied scholarship, including growing recognition that they might defy efforts to map them neatly onto a “biological” and “cultural” binary.1 In line with the Sex and Gender Equity in Research (SAGER) guidelines,7 which the journal endorses, these terms should be clearly defined by authors and used with precision and consistency throughout their work. The goal of this special issue is to provide a platform for research and analysis that engage with what gender means for Australian health care in a manner informed by evidence, scientific rigour, a quest for equity and justice and, fundamentally, respect for the rights, dignity and perspectives of affected populations. Its curation was premised on an understanding of gender as “the structure of social relations and practices that are organised in relation to reproductive bodies”.8

The articles in this issue cover diverse ground. Harsha Ananthram and colleagues9 seek to unpack the term “obstetric violence” in the context of findings from recent inquiries into birth trauma in Australia and the United Kingdom. In Australia, practitioners who refuse to participate in abortion care should refer their patients onwards to a willing provider. Shelly Makeleff and colleagues10 argue that not enough attention has been given to how these referrals are carried out and propose strategies to promote person-centred abortion referrals. The potential to improve the care of people with anxiety disorders through sex- and gender-responsive management approaches is explored by Bronwyn Graham,11 who notes that sex and gender are relatively ignored in anxiety disorder research, medical curricula, and clinical guidelines. Findings from a cohort study done in New South Wales show that although the gender gap in the treatment and outcomes of ST-elevation myocardial infarction (STEMI) has narrowed in recent years, the high disparity between male and female patients with STEMI is unlikely to close in the next decade.12 And a pharmacoepidemiology study from Kailash Thapaliya and colleagues13 highlights gaps in evidence and guidance for the prescribing of glucagon-like peptide-1 (GLP-1) receptor agonists for women of reproductive age.

Three articles in this special issue specifically address trans health. First, Kade Booth and colleagues14 discuss the disparities faced by trans and gender diverse people in accessing cervical cancer screening and vaccination against human papillomavirus, and propose several potential solutions. Second, a perspective article by Julia Moore and colleagues15 engages with the Independent review of gender identity services for children and young people, or Cass Review, commissioned by England's National Health Service and published in 2024.16 The authors critique the findings of the Review on several grounds, including a lack of representation of the views of trans adolescents, and ultimately conclude the review represents a “failure of evidence-based medicine”. “Good medicine” they contend “is guided by the values of the patient, not those of a clinician, politician or commentator. A patient's goal of achieving optimal quality of life as a trans person requires respect”.

This point is directly addressed by the third article on trans health in this issue, from Jayne McFadyen and colleagues.17 In 1987, the MJA published the report of a case series of eight gender diverse children.18 To correct what was termed their “cross-gender behaviour”, these children had been administered “therapy” as inpatients for between six and 28 weeks. The report concluded that “the treatment of cross-gender behaviour by means of inpatient therapy seems effective”. It continues to be cited in contemporary debates about young people's access to gender affirming care and about so-called conversion therapy. Decades later, the MJA was approached by Jayne and her co-authors with a request to consider an article in response to this work: Jayne is a trans woman who reasonably believes, on the basis of evidence available to her, that she was one of the children described in the 1987 article. The author team had undertaken an analysis of archived mental health records, published details from the 1987 case series, and Jayne's autoethnographic account of her treatment, and concluded that the inpatient treatment Jayne had received constituted a form of conversion therapy aimed at “extinguishing childhood behaviours deemed to be socially undesirable”. Despite the claim from the 1987 report that this treatment appeared effective, for Jayne the attempt to change or suppress her gender identity “served to delay self-acceptance for two decades and caused long term harm”.

As journal editors, at the forefront of our minds every time we decide to publish an article are questions about the potential harms that could result from our decision. We must ask ourselves: are we confident the findings reported are legitimate, produced ethically, analysed appropriately, and reported in a balanced and transparent manner? Could our decisions inadvertently contribute to undermining public trust in science or to supporting ineffective or even harmful medical practices? To mitigate these concerns, we take expert advice from peer reviewers and consider it carefully in the context of what has been previously published. We have no reason to believe that those involved in the 1987 MJA article had anything but the best intentions, given the knowledge and dominant gender norms of the day. But what is apparent is that the practices of medicine and scholarly publishing at the time did not place sufficient value on the views, experiences and preferences of the young people whose wellbeing was at stake. Genuine evidence-based medicine requires epistemic pluralism, including understanding the value of patient voices. This is where the work of Jayne and her colleagues becomes particularly important.

At the MJA, we appreciate the power imbalances at play here. These exist between medical experts with professional standing, a scholarly journal with an established national reputation, and a patient, who at the time the “inpatient treatment” was administered was a child. In this context, we are immensely grateful that Jayne and her co-authors chose to entrust their work to the MJA for consideration. As editors, we are also grateful for the opportunity this experience has afforded us to reflect and act on what it means to demonstrate institutional accountability for past decisions. What constitutes the best care for trans young people should of course be up for debate, as is the case for all areas of medicine. It is the role of medical journals to ensure that this debate is rooted in humane values and is driven by evidence — of which the views of patients are an essential part.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medical Journal of Australia
Medical Journal of Australia 医学-医学:内科
CiteScore
9.40
自引率
5.30%
发文量
410
审稿时长
3-8 weeks
期刊介绍: The Medical Journal of Australia (MJA) stands as Australia's foremost general medical journal, leading the dissemination of high-quality research and commentary to shape health policy and influence medical practices within the country. Under the leadership of Professor Virginia Barbour, the expert editorial team at MJA is dedicated to providing authors with a constructive and collaborative peer-review and publication process. Established in 1914, the MJA has evolved into a modern journal that upholds its founding values, maintaining a commitment to supporting the medical profession by delivering high-quality and pertinent information essential to medical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信